These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 36292247)
1. Multiregional Radiomic Signatures Based on Functional Parametric Maps from DCE-MRI for Preoperative Identification of Estrogen Receptor and Progesterone Receptor Status in Breast Cancer. Zhong S; Wang F; Wang Z; Zhou M; Li C; Yin J Diagnostics (Basel); 2022 Oct; 12(10):. PubMed ID: 36292247 [TBL] [Abstract][Full Text] [Related]
2. Intratumoral and Peritumoral Radiomics Based on Functional Parametric Maps from Breast DCE-MRI for Prediction of HER-2 and Ki-67 Status. Li C; Song L; Yin J J Magn Reson Imaging; 2021 Sep; 54(3):703-714. PubMed ID: 33955619 [TBL] [Abstract][Full Text] [Related]
3. Intratumoral and Peritumoral Analysis of Mammography, Tomosynthesis, and Multiparametric MRI for Predicting Ki-67 Level in Breast Cancer: a Radiomics-Based Study. Jiang T; Song J; Wang X; Niu S; Zhao N; Dong Y; Wang X; Luo Y; Jiang X Mol Imaging Biol; 2022 Aug; 24(4):550-559. PubMed ID: 34904187 [TBL] [Abstract][Full Text] [Related]
4. Intratumoral and peritumoral radiomics based on dynamic contrast-enhanced MRI for preoperative prediction of intraductal component in invasive breast cancer. Xu H; Liu J; Chen Z; Wang C; Liu Y; Wang M; Zhou P; Luo H; Ren J Eur Radiol; 2022 Jul; 32(7):4845-4856. PubMed ID: 35079887 [TBL] [Abstract][Full Text] [Related]
5. Intra- and peri-tumoral radiomics for predicting the sentinel lymph node metastasis in breast cancer based on preoperative mammography and MRI. Cheng Y; Xu S; Wang H; Wang X; Niu S; Luo Y; Zhao N Front Oncol; 2022; 12():1047572. PubMed ID: 36578933 [TBL] [Abstract][Full Text] [Related]
6. MRI-based multiregional radiomics for predicting lymph nodes status and prognosis in patients with resectable rectal cancer. Li H; Chen XL; Liu H; Lu T; Li ZL Front Oncol; 2022; 12():1087882. PubMed ID: 36686763 [TBL] [Abstract][Full Text] [Related]
7. Radiomic Signatures Based on Mammography and Magnetic Resonance Imaging as New Markers for Estimation of Ki-67 and HER-2 Status in Breast Cancer. Fan Y; Zhao D; Su J; Yuan W; Niu S; Guo W; Jiang W J Comput Assist Tomogr; 2023 Nov-Dec 01; 47(6):890-897. PubMed ID: 37948363 [TBL] [Abstract][Full Text] [Related]
8. Radiomics analysis of intratumoral and different peritumoral regions from multiparametric MRI for evaluating HER2 status of breast cancer: A comparative study. Zhou J; Yu X; Wu Q; Wu Y; Fu C; Wang Y; Hai M; Tan H; Wang M Heliyon; 2024 Apr; 10(7):e28722. PubMed ID: 38623231 [TBL] [Abstract][Full Text] [Related]
9. Preoperative prediction of sentinel lymph node metastasis in breast cancer by radiomic signatures from dynamic contrast-enhanced MRI. Liu C; Ding J; Spuhler K; Gao Y; Serrano Sosa M; Moriarty M; Hussain S; He X; Liang C; Huang C J Magn Reson Imaging; 2019 Jan; 49(1):131-140. PubMed ID: 30171822 [TBL] [Abstract][Full Text] [Related]
10. Intra- and peritumoral radiomics on assessment of breast cancer molecular subtypes based on mammography and MRI. Niu S; Jiang W; Zhao N; Jiang T; Dong Y; Luo Y; Yu T; Jiang X J Cancer Res Clin Oncol; 2022 Jan; 148(1):97-106. PubMed ID: 34623517 [TBL] [Abstract][Full Text] [Related]
11. Using Radiomics to Differentiate Brain Metastases From Lung Cancer Versus Breast Cancer, Including Predicting Epidermal Growth Factor Receptor and human Epidermal Growth Factor Receptor 2 Status. Shi J; Chen H; Wang X; Cao R; Chen Y; Cheng Y; Pang Z; Huang C J Comput Assist Tomogr; 2023 Nov-Dec 01; 47(6):924-933. PubMed ID: 37948368 [TBL] [Abstract][Full Text] [Related]
12. Intra- and Peritumoral Radiomics Model Based on Early DCE-MRI for Preoperative Prediction of Molecular Subtypes in Invasive Ductal Breast Carcinoma: A Multitask Machine Learning Study. Zhang S; Wang X; Yang Z; Zhu Y; Zhao N; Li Y; He J; Sun H; Xie Z Front Oncol; 2022; 12():905551. PubMed ID: 35814460 [TBL] [Abstract][Full Text] [Related]
13. Intratumoral and Peritumoral Radiomics Based on Preoperative MRI for Evaluation of Programmed Cell Death Ligand-1 Expression in Breast Cancer. Wu Z; Lin Q; Wang H; Chen J; Wang G; Fu G; Li L; Bian T J Magn Reson Imaging; 2024 Aug; 60(2):588-599. PubMed ID: 37916918 [TBL] [Abstract][Full Text] [Related]
14. Clinical study on the prediction of ALN metastasis based on intratumoral and peritumoral DCE-MRI radiomics and clinico-radiological characteristics in breast cancer. Wang Y; Shang Y; Guo Y; Hai M; Gao Y; Wu Q; Li S; Liao J; Sun X; Wu Y; Wang M; Tan H Front Oncol; 2024; 14():1357145. PubMed ID: 38567148 [TBL] [Abstract][Full Text] [Related]
15. Intratumoral and Peritumoral Multiparametric MRI-Based Radiomics Signature for Preoperative Prediction of Ki-67 Proliferation Status in Glioblastoma: A Two-Center Study. Zhu X; He Y; Wang M; Shu Y; Lai X; Gan C; Liu L Acad Radiol; 2024 Apr; 31(4):1560-1571. PubMed ID: 37865602 [TBL] [Abstract][Full Text] [Related]
16. Radiomic Signatures for Predicting Receptor Status in Breast Cancer Brain Metastases. Luo X; Xie H; Yang Y; Zhang C; Zhang Y; Li Y; Yang Q; Wang D; Luo Y; Mai Z; Xie C; Yin S Front Oncol; 2022; 12():878388. PubMed ID: 35734585 [TBL] [Abstract][Full Text] [Related]
17. Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI. Braman NM; Etesami M; Prasanna P; Dubchuk C; Gilmore H; Tiwari P; Plecha D; Madabhushi A Breast Cancer Res; 2017 May; 19(1):57. PubMed ID: 28521821 [TBL] [Abstract][Full Text] [Related]
18. Multiregional radiomics of brain metastasis can predict response to EGFR-TKI in metastatic NSCLC. Fan Y; Wang X; Dong Y; Cui E; Wang H; Sun X; Su J; Luo Y; Yu T; Jiang X Eur Radiol; 2023 Nov; 33(11):7902-7912. PubMed ID: 37142868 [TBL] [Abstract][Full Text] [Related]
19. Development and Internal Validation of a Preoperative Prediction Model for Sentinel Lymph Node Status in Breast Cancer: Combining Radiomics Signature and Clinical Factors. Wang C; Chen X; Luo H; Liu Y; Meng R; Wang M; Liu S; Xu G; Ren J; Zhou P Front Oncol; 2021; 11():754843. PubMed ID: 34820327 [TBL] [Abstract][Full Text] [Related]
20. Radiomics Nomogram Based on Radiomics Score from Multiregional Diffusion-Weighted MRI and Clinical Factors for Evaluating HER-2 2+ Status of Breast Cancer. Li C; Yin J Diagnostics (Basel); 2021 Aug; 11(8):. PubMed ID: 34441425 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]